You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 28, 2025

Claims for Patent: 9,687,611

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,687,611

Title:	Injection device with torsion spring and rotatable display
Abstract:	The present invention relates to an injection device comprising a torsion spring operatively connected to a dose setting member being adapted to set a dose to be ejected from the injection device. A rotatably mounted display member adapted to display the dose to be ejected in accordance with a setting of the dose setting member is also provided. The rotatably mounted display member is adapted to be rotated over an angle corresponding to at least one revolution of the display member. The display member may be implemented as a dose indicator barrel having numerals arranged along a helical path on an outer surface thereof, or alternatively, as a counting device having two or more display wheels having numerals arranged on an outer surface thereof.
Inventor(s):	Moeller Claus Schmidt, Markussen Tom Hede, Enggaard Christian Peter
Assignee:	Novo Nordisk A/S
Application Number:	US14167558
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,687,611
Patent Claims:

Details for Patent 9,687,611

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	June 16, 2005	⤷ Get Started Free	2034-01-29
Novo Nordisk Inc.	LEVEMIR	insulin detemir	Injection	021536	October 31, 2013	⤷ Get Started Free	2034-01-29
Novo Nordisk Inc.	NOVOLOG MIX 50/50	insulin aspart protamine and insulin aspart	Injectable Suspension	021810	August 26, 2008	⤷ Get Started Free	2034-01-29
Seqirus Inc.	FLUAD	influenza vaccine, adjuvanted	Injection	125510	November 24, 2015	⤷ Get Started Free	2034-01-29
Seqirus Inc.	FLUAD,FLUAD QUADRIVALENT	influenza vaccine, adjuvanted	Injection	125510	February 21, 2020	⤷ Get Started Free	2034-01-29
Novo Nordisk Inc.	TRESIBA	insulin degludec	Injection	203314	September 25, 2015	⤷ Get Started Free	2034-01-29
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 9,687,611

Subscribe to access the full database, or Get Started Free
Country	Patent Number	Estimated Expiration
South Africa	200703706	⤷ Get Started Free
World Intellectual Property Organization (WIPO)	2006045528	⤷ Get Started Free
United States of America	8684969	⤷ Get Started Free
United States of America	8357120	⤷ Get Started Free
United States of America	2022379036	⤷ Get Started Free
United States of America	2020030541	⤷ Get Started Free
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.